https://insights.citeline.com/hbw-insight/beauty/business/earnings/beiersdorf-sees-early-gains-in-nivea-strategy-despite-tough-q1-PZXIVGAZHRFGNAHIRCX7XZ6M6Y/2026-04-22T23:48:18.237Zalways0.5Insightsen2026-04-22T23:48:18.237Zhttps://insights.citeline.com/resizer/JmWKFJxAJgncFOB0k3i1qI9SGE8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2OYMQ7Z3RBDL7CJ6RPX2IR4FMQ.jpghttps://insights.citeline.com/scrip/therapeutic-category/cardiovascular/bioage-outlines-clinical-expansion-plans-for-bge-102-G3EBRD5MCRC35FFYPRDOAQNEHQ/2026-04-22T22:33:48.853Zalways0.5Insightsen2026-04-22T22:33:48.853Zhttps://insights.citeline.com/resizer/aukOI4oyRF0xvM8c7mtbbwU9fYQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/U5JLXIX3IVG2JPOO4JKXGYRNHY.jpghttps://insights.citeline.com/scrip/advanced-therapies/cell-therapies/a-single-dose-changes-the-conversation-car-t-arrives-in-autoimmune-neurology-O6E7SXJF75GQZM6YXV3DQGLENE/2026-04-22T21:50:33.814Zalways0.5Insightsen2026-04-22T21:50:33.814Zhttps://insights.citeline.com/resizer/2CqpP9JnNweGjlryPY_XluI-w48=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BCKA3QJLG5DBLJSPKV4JZ37XCQ.jpghttps://insights.citeline.com/scrip/business/start-ups-and-smes/emerging-company-profiles/how-not-to-get-ghosted-by-pharma-and-other-biotech-partnering-tips-EECBWRXPMFBEVMJPRIQKAMS74A/2026-04-22T21:49:43.371Zalways0.5Insightsen2026-04-22T21:49:43.371Zhttps://insights.citeline.com/resizer/PIB9mg7s6d32s9bXw35OLP_tIyo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/V6L7LYDL4ZGY7A2PW33V5AFOZM.jpghttps://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-first-tracks-completes-spinout-from-anaptysbio-OGXTK6PLHZHKZETVUXXAQREOEE/2026-04-22T21:49:27.183Zalways0.5Insightsen2026-04-22T21:49:27.183Zhttps://insights.citeline.com/resizer/QP0XsTOKIkbEiMw2sxA1vTD-XIs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UUPCCTOSUNI7ZKUU3DO7RIZNHI.jpghttps://insights.citeline.com/scrip/business/strategy/puretechs-gallop-maintains-steady-gait-in-mds-after-strong-showing-for-lyt-200-YCSRRBHABFH5TPBY335MIWITRY/2026-04-22T21:49:05.255Zalways0.5Insightsen2026-04-22T21:49:05.255Zhttps://insights.citeline.com/resizer/E8apOm7S2h15pQF79-tXjdYaGAs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/THNEVTSEABOHNJJ4YWPIJXCKUM.jpghttps://insights.citeline.com/scrip/new-products/idvynso-approval-gives-merck-a-competitor-in-once-daily-oral-hiv-market-O2T5RFF4KBHHTDATURNSWRCNBI/2026-04-22T21:48:11.365Zalways0.5Insightsen2026-04-22T21:48:11.365Zhttps://insights.citeline.com/resizer/s2-cu0qxtWqLUzuZgmjGaSx6LBk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BUR5WUO6CNP3BJY77FILLPXVR4.jpghttps://insights.citeline.com/pink-sheet/rare-diseases/data-sharing-financial-incentives-needed-but-plausible-mechanism-is-a-catalyst-QMJ7JJ5SWNGBVKBZCNFBJLDXZQ/2026-04-22T21:26:55.412Zalways0.5Insightsen2026-04-22T21:26:55.412Zhttps://insights.citeline.com/resizer/qIF0MmCRoWRyf-Isvh8UVIMWRjA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/MM2B5GR75RDQFMCPD2TC3SEN4U.jpghttps://insights.citeline.com/hbw-insight/wellness/policy-and-regulation/regulation/expanding-otc-choices-in-us-confuse-consumers-while-increasing-out-of-pocket-costs-UYBO7PYWCZD33DJNAQX5EHT7XM/2026-04-22T21:17:53.145Zalways0.5Insightsen2026-04-22T21:17:53.145Zhttps://insights.citeline.com/resizer/F_kYnTpdfMnxDRJXWeXuWjVDVR8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UJB3UQZB6RAYPCVXZJTYQVT2GQ.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/us-fda/medcon-day-1-mdufa-negotiators-tout-historic-timeline-in-reaching-agreement-on-user-fees-JNN7ABNEIZBTPBD5Z7LIGQMJLM/2026-04-22T21:17:40.359Zalways0.5Insightsen2026-04-22T21:17:40.359Zhttps://insights.citeline.com/resizer/ptDBVW5KpM_8rPeQ04iKq7SrTZA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZNNOVGE5NNGEXGW6POID4AI5HU.jpghttps://insights.citeline.com/generics-bulletin/balance-model-delay-may-lead-to-revisions-higher-near-term-medicare-costs-B4LSH6CVIVGNRIPNVL5JIOR7YQ/2026-04-22T21:10:05.639Zalways0.5Insightsen2026-04-22T21:10:05.639Zhttps://insights.citeline.com/resizer/8Bc-QR8-PBB_u1TPiqlw-2adyos=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JCLPB4PCYFDR7BBMJTR4ZWBCGQ.jpghttps://insights.citeline.com/pink-sheet/product-reviews/complete-response-letters/drug-industry-escalates-fight-over-us-fda-crl-disclosures-seeks-redaction-role-OWFUTNDHVRFQ7DLQ4EVOMVNDPA/2026-04-22T21:09:42.222Zalways0.5Insightsen2026-04-22T21:09:42.222Zhttps://insights.citeline.com/resizer/jrcaGB1_SOxp_20Fb8LSA_vAPaY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UUIERV25C5CFRD6G6BL2PTSPOY.jpghttps://insights.citeline.com/medtech-insight/business/strategy/luminoah-aims-to-deliver-personalized-data-driven-nutrition-and-dignity-for-tube-fed-patients-BILQOQ4A2ZBQJPSZPBCRH2TEZE/2026-04-22T20:45:55.924Zalways0.5Insightsen2026-04-22T20:45:55.924Zhttps://insights.citeline.com/resizer/xZap5TuoeWhLyw-yNNx1o6oKv6U=/cloudfront-us-east-1.images.arcpublishing.com/norstella/S2FCIAIEGJGE7F47IM4G322BEM.pnghttps://insights.citeline.com/medtech-insight/business/earnings/danaher-signals-ma-capacity-for-more-deals-even-as-99bn-masimo-integration-begins-UCHJRJNLAVC6JLKSTJXFFVKSLM/2026-04-22T18:47:20.191Zalways0.5Insightsen2026-04-22T18:47:20.191Zhttps://insights.citeline.com/resizer/CTta3nnMlD4Q400WhALDl3lLW_c=/cloudfront-us-east-1.images.arcpublishing.com/norstella/56IHCXBS3NCMRGTE2BTQEDSO4I.jpghttps://insights.citeline.com/medtech-insight/business/earnings/intuitive-raises-2026-growth-outlook-as-da-vinci-5-drives-utilization-growth-CSHWAXY52BBMFDPOSU7S4GZTHM/2026-04-22T18:23:03.865Zalways0.5Insightsen2026-04-22T18:23:03.865Zhttps://insights.citeline.com/resizer/tLbj0TiZBgWHnwIhb9txc9wnFmw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/C33EFYKGJFD3VDITCONLEQ4GNQ.jpghttps://insights.citeline.com/scrip/r-and-d/reducing-uncertainty-in-early-oral-drug-development-decisions-that-benefit-from-predictive-insights-FS4MVISAPVD3VPKCW7BJHHPOU4/2026-04-22T17:43:18.329Zalways0.5Insightsen2026-04-22T17:43:18.329Zhttps://insights.citeline.com/resizer/xcW5Ju6Ty0ZSR1wYHZ0s95mB9gk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/EVVSPOMIJ5GFNE23TCQJUU2FQY.jpghttps://insights.citeline.com/scrip/r-and-d/guided-by-vision-redefining-osd-development-through-foresight-and-innovation-TRJQ5NJLWVC4LGZBGM3BQ4N4II/2026-04-22T17:41:37.043Zalways0.5Insightsen2026-04-22T17:41:37.043Zhttps://insights.citeline.com/resizer/iF7wbGtwADyOq2uklR4EOLbsbQI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/35B6YVMNGBECZOSRQBWIWAT7OI.jpghttps://insights.citeline.com/scrip/r-and-d/accelerator-drug-development-streamlining-preclinical-pathways-for-a-fast-transition-to-first-in-h-BQZYIXZIYRDLFBLJZQSLV6MTKA/2026-04-22T17:38:53.473Zalways0.5Insightsen2026-04-22T17:38:53.473Zhttps://insights.citeline.com/resizer/SLUACXoQl4r1b1Z635X9xnVcYZs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/LIC6URVE25EAHGBO546BV374WY.jpghttps://insights.citeline.com/scrip/r-and-d/scaling-biologics-from-late-stage-development-to-commercialization-PCVRWYDUVFHZNE6AER2UQ6JROI/2026-04-22T17:36:44.946Zalways0.5Insightsen2026-04-22T17:36:44.946Zhttps://insights.citeline.com/resizer/6X0TorFEuIdLk7RW4suqTHeDBFY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/VQIR7IK5OVFH3BONFSBDKYOVVY.pnghttps://insights.citeline.com/scrip/r-and-d/early-phase-injectable-formulation-development-HKROTVWRFFDFBD5HYYBNVIXT6Y/2026-04-22T17:34:31.878Zalways0.5Insightsen2026-04-22T17:34:31.878Zhttps://insights.citeline.com/resizer/hvO8eQEE1KeE2FAaUZU4VbOVoVY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7I23Z3YIG5DGDPK4KCIO6VQYYA.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-supply-flexibility-where-biotech-programs-need-it-most-PJLVQGQ66VHFNC7XQPZ5UTEG7Y/2026-04-22T17:32:06.727Zalways0.5Insightsen2026-04-22T17:32:06.727Zhttps://insights.citeline.com/resizer/1nzKkoZ0tFzgB37wQo-uUoC9u74=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JZCBQ64JX5CVHB5F7EIRPHPKCA.jpghttps://insights.citeline.com/in-vivo/innovation/advanced-therapies/partial-inhibition-full-ambition-regeneron-bets-its-neurology-future-on-cemdisiran-HK7CWNQ4SJH6PGPEL6M5RG6NQI/2026-04-22T16:07:19.309Zalways0.5Insightsen2026-04-22T16:07:19.309Zhttps://insights.citeline.com/resizer/oRNQFH6JYD-ws34fnBzMp64dhZM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/NVEKL5ZMGRIHPGHYVAAMPJESAA.jpghttps://insights.citeline.com/pink-sheet/sandoz-builds-new-model-for-african-drug-access-6LIZTU2XZVCZBLDOGKMQHBJQPY/2026-04-22T14:03:23.421Zalways0.5Insightsen2026-04-22T14:03:23.421Zhttps://insights.citeline.com/resizer/t_9iEHCwRrP3Xq2eIY6J6nLdXBw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/AYWGEWI3FVPLZJ5S364BSXHNGA.jpghttps://insights.citeline.com/hbw-insight/beauty/policy-and-regulation/eu-parliament-grants-industry-wins-rejects-some-demands-in-omnibus-proposal-ZBEHEELV5FCUJM7PYTUKQPSSLY/2026-04-22T13:31:10.321Zalways0.5Insightsen2026-04-22T13:31:10.321Zhttps://insights.citeline.com/resizer/Xfp4lX0KsEDTDcqlaoJvM5VuFVo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UUYSTYBPKJIAVHDMQZ2OCOW46Q.jpghttps://insights.citeline.com/pink-sheet/policy-regulation/iran-war-exposes-weaknesses-in-pharma-resilience-planning-4GE6OKSHV5B5HMEKPKYW4XMW4U/2026-04-22T12:09:17.623Zalways0.5Insightsen2026-04-22T12:09:17.623Zhttps://insights.citeline.com/resizer/Ln63XBY_TCgXiQmMKS8_cJaxnhw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/EDB3OCKQKFFXNCYIPLTXDGYZUY.jpghttps://insights.citeline.com/generics-bulletin/products/biosimilars/amneals-bevacizumab-biosimilar-brochure-rebuked-by-fdas-opdp-P47PAJGXCVGOLAVEJVGNSN4Y7U/2026-04-22T11:18:38.7Zalways0.5Insightsen2026-04-22T11:18:38.7Zhttps://insights.citeline.com/resizer/BJ_3nlyCC53-nWYAK4zkSv-bA24=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WCSYPWLACRC3TJBN7QTFRT4YE4.jpghttps://insights.citeline.com/generics-bulletin/market-intelligence/pricewatch-UK/steep-uk-generic-price-rises-continue-in-march-52YM36JTTVEA3O2K3LZCJELYNI/2026-04-22T11:18:34.037Zalways0.5Insightsen2026-04-22T11:18:34.037Zhttps://insights.citeline.com/resizer/n8VxkjQ5SuPxxOduGuYyH7Vj0j0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/AZ2J5HSSQRLOZCUNFONHZZWIRU.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/roche-upbeat-on-fenebrutinib-filing-prospects-despite-safety-questions-RRQ6HF6KY5DAHJHMNMPXH2VJ2A/2026-04-22T09:50:06.671Zalways0.5Insightsen2026-04-22T09:50:06.671Zhttps://insights.citeline.com/resizer/yhVnDVgRwgRvoF9u1XVB6W5IFVA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IUHIP2CXIBLCXF7HINS6SDJPY4.jpghttps://insights.citeline.com/in-vivo/innovation/pharmas-pipeline-size-dipped-in-2025-MI2I4JR3QNDMPMRJYGM2VK535Q/2026-04-22T08:43:11.963Zalways0.5Insightsen2026-04-22T08:43:11.963Zhttps://insights.citeline.com/resizer/Hom2RaGsQIPllgfuE0JOatrrM8M=/cloudfront-us-east-1.images.arcpublishing.com/norstella/PMTQESIGZJF5XI3AXUH6XSC3WE.jpghttps://insights.citeline.com/in-vivo/market-intelligence/the-10-80-10-investment-rule-preparation-is-all-JENCTEIDBJHZLH55HG2CXZ63AA/2026-04-22T08:40:07.111Zalways0.5Insightsen2026-04-22T08:40:07.111Zhttps://insights.citeline.com/resizer/jhjyfXsWhbuRdGstOf2IfLXLF04=/cloudfront-us-east-1.images.arcpublishing.com/norstella/CZ56BTKN3JCHHOS67BXT7YBZ3I.jpeghttps://insights.citeline.com/medtech-insight/policy-and-regulation/eu/ai-medtech-regulation-in-limbo-after-eu-rules-simplification-XLJXY5H45ZHDTIGCDZBC4RRUAY/2026-04-22T08:35:46.778Zalways0.5Insightsen2026-04-22T08:35:46.778Zhttps://insights.citeline.com/resizer/iklEGrqK4B3Mo1zvu3jcLRw1fSY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XIDGMQGNB5AXRJJR7HOAFKT4X4.jpghttps://insights.citeline.com/generics-bulletin/podcasts/the-generics-bulletin-podcast-green-regulations-with-medicines-for-europes-adrian-van-den-hoven-4BV5RHLRSZETVELG4YCXNCDPI4/2026-04-22T08:14:23.108Zalways0.5Insightsen2026-04-22T08:14:23.108Zhttps://insights.citeline.com/resizer/cHRi6WKMIiDkRXoVszJPOiAvMw8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6KUUA6XEEVLBRAQY3AF4FXXMSM.jpghttps://insights.citeline.com/hbw-insight/wellness/policy-and-regulation/incomprehensible-french-cbd-association-slams-sudden-clamp-down-IFWLA5WCSBGZVEKY77REW4JIQA/2026-04-22T08:08:22.506Zalways0.5Insightsen2026-04-22T08:08:22.506Zhttps://insights.citeline.com/resizer/Nm8MWR2BHKrv0Zcdta_IGTPU1vY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QJYIZBCCY5IQDAR4AHOHGDCPEI.jpghttps://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/vijoice-back-on-the-table-as-novartis-set-to-discuss-new-alpelisib-filing-with-ema-2V5GN3YBKFCA3AN4IFH7U5NQ2Y/2026-04-22T07:40:14.649Zalways0.5Insightsen2026-04-22T07:40:14.649Zhttps://insights.citeline.com/resizer/lmhgvCrIiKC31_bbUxcypkLbp6w=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7OHFKL5XAJFEZKBIPTYMW6M2BQ.jpghttps://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/ema-decision-time-for-novartis-intrathecal-sma-gene-therapy-five-others-KLNUMWSBQBD3LPQWCQ5RIRJX24/2026-04-22T07:39:26.012Zalways0.5Insightsen2026-04-22T07:39:26.012Zhttps://insights.citeline.com/resizer/DCCHegvvMjDr3GxiNkzWUOxz2bg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZCCEAJHICZLQTAQVOBEYDVNVAU.jpghttps://insights.citeline.com/pink-sheet/market-access/government-payers/cms-prior-authorization-proposal-could-ease-processing-burden-costs-but-not-suppress-use-AZSYVJ6WSZFS7M7FVKAGIABORE/2026-04-22T07:37:26.818Zalways0.5Insightsen2026-04-22T07:37:26.818Zhttps://insights.citeline.com/resizer/XGbue-wRutMvtZtxIosRixKYc90=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3DOVFRKCPVD3NODRXD2HMZGVRE.jpghttps://insights.citeline.com/pink-sheet/pathways-and-standards/review-pathways/us-fda-looks-beyond-monoclonal-antibodies-to-encourage-animal-testing-alternatives-B4IC4F2BOFAJXME33BKWL4FQEA/2026-04-22T07:36:46.329Zalways0.5Insightsen2026-04-22T07:36:46.329Zhttps://insights.citeline.com/resizer/XjEK8yy69rYtmYy1v22n4bKexI4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/B4SYG2UZARFO5A6Q52RJRIOOP4.jpghttps://insights.citeline.com/pink-sheet/rare-diseases/rare-disease-advocates-question-added-value-of-fdas-plausible-mechanism-pathway-WBZ5QB2VVNDZDAXYP5NTADBK2Y/2026-04-22T07:36:05.099Zalways0.5Insightsen2026-04-22T07:36:05.099Zhttps://insights.citeline.com/resizer/xOZ18pA5fU9fkSCxTQe2TiITS-k=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GWT2HMV37RBEBL465J7E6EZX7U.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/merck-and-eisais-keytrudalenvimawelireg-trial-in-kidney-cancer-fails-4Y4GLHJNSNEKJEEHU4DP3SKAWI/2026-04-22T01:53:30.68Zalways0.5Insightsen2026-04-22T01:53:30.68Zhttps://insights.citeline.com/resizer/WxX9Xf9eEgIB2Bb9MbdNKmAlvpk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UP76E7SA6BEEZI57KMIZNYSS5E.jpghttps://insights.citeline.com/companies/laronix-inc/2026-04-22T00:06:01.766Zalways0.5Insightsen2026-04-22T00:06:01.766Zhttps://insights.citeline.com/companies/screenpoint-medical/2026-04-22T00:05:47.704Zalways0.5Insightsen2026-04-22T00:05:47.704Zhttps://insights.citeline.com/companies/evon-medics-llc/2026-04-22T00:05:37.575Zalways0.5Insightsen2026-04-22T00:05:37.575Zhttps://insights.citeline.com/companies/jiangsu-kunli-biopharmaceutical-co-ltd/2026-04-22T00:05:31.479Zalways0.5Insightsen2026-04-22T00:05:31.479Zhttps://insights.citeline.com/companies/chengdu-chipscreen-pharmaceutical-co-ltd/2026-04-22T00:05:25.469Zalways0.5Insightsen2026-04-22T00:05:25.469Zhttps://insights.citeline.com/companies/clonell-therapeutics-inc/2026-04-22T00:05:19.37Zalways0.5Insightsen2026-04-22T00:05:19.37Zhttps://insights.citeline.com/companies/t-e-meds-inc/2026-04-22T00:05:13.477Zalways0.5Insightsen2026-04-22T00:05:13.477Zhttps://insights.citeline.com/companies/kalohexis-llc2026-04-22T00:05:07.485Zalways0.5Insightsen2026-04-22T00:05:07.485Zhttps://insights.citeline.com/companies/caladrix-inc2026-04-22T00:05:01.455Zalways0.5Insightsen2026-04-22T00:05:01.455Zhttps://insights.citeline.com/companies/lexbio2026-04-22T00:04:55.364Zalways0.5Insightsen2026-04-22T00:04:55.364Zhttps://insights.citeline.com/companies/byterna-therapeutics-ltd2026-04-22T00:04:49.308Zalways0.5Insightsen2026-04-22T00:04:49.308Zhttps://insights.citeline.com/companies/synthetic-design-lab2026-04-22T00:04:43.374Zalways0.5Insightsen2026-04-22T00:04:43.374Zhttps://insights.citeline.com/companies/35pharma2026-04-22T00:04:31.315Zalways0.5Insightsen2026-04-22T00:04:31.315Zhttps://insights.citeline.com/companies/tarsus-pharmaceuticals-inc2026-04-22T00:04:25.269Zalways0.5Insightsen2026-04-22T00:04:25.269Zhttps://insights.citeline.com/companies/episurf-medical-ab2026-04-22T00:04:19.379Zalways0.5Insightsen2026-04-22T00:04:19.379Zhttps://insights.citeline.com/companies/poltreg-sa2026-04-22T00:04:13.226Zalways0.5Insightsen2026-04-22T00:04:13.226Zhttps://insights.citeline.com/companies/klotho-neurosciences-inc2026-04-22T00:04:07.19Zalways0.5Insightsen2026-04-22T00:04:07.19Zhttps://insights.citeline.com/companies/amphista-therapeutics2026-04-22T00:04:01.13Zalways0.5Insightsen2026-04-22T00:04:01.13Zhttps://insights.citeline.com/companies/applied-dna-sciences-inc2026-04-22T00:03:55.104Zalways0.5Insightsen2026-04-22T00:03:55.104Zhttps://insights.citeline.com/companies/transcend-therapeutics2026-04-22T00:03:49.048Zalways0.5Insightsen2026-04-22T00:03:49.048Zhttps://insights.citeline.com/companies/viracta-therapeutics-inc2026-04-22T00:03:43.066Zalways0.5Insightsen2026-04-22T00:03:43.066Zhttps://insights.citeline.com/companies/tulex-pharmaceuticals-inc2026-04-22T00:03:37.008Zalways0.5Insightsen2026-04-22T00:03:37.008Zhttps://insights.citeline.com/companies/keymed-biosciences-inc2026-04-22T00:03:31.056Zalways0.5Insightsen2026-04-22T00:03:31.056Zhttps://insights.citeline.com/companies/qsam-biosciences2026-04-22T00:03:25.016Zalways0.5Insightsen2026-04-22T00:03:25.016Zhttps://insights.citeline.com/companies/national-cheng-kung-university2026-04-22T00:03:18.825Zalways0.5Insightsen2026-04-22T00:03:18.825Zhttps://insights.citeline.com/companies/innocan-pharma-corp2026-04-22T00:03:12.837Zalways0.5Insightsen2026-04-22T00:03:12.837Zhttps://insights.citeline.com/companies/redwood-pharma-ab2026-04-22T00:03:06.862Zalways0.5Insightsen2026-04-22T00:03:06.862Zhttps://insights.citeline.com/companies/devonian-health-group-inc2026-04-22T00:03:00.96Zalways0.5Insightsen2026-04-22T00:03:00.96Zhttps://insights.citeline.com/companies/nextcure-inc2026-04-22T00:02:54.955Zalways0.5Insightsen2026-04-22T00:02:54.955Zhttps://insights.citeline.com/companies/tivic-health-systems-inc2026-04-22T00:02:48.608Zalways0.5Insightsen2026-04-22T00:02:48.608Zhttps://insights.citeline.com/companies/chiesi-farmaceutici-spa2026-04-22T00:02:42.703Zalways0.5Insightsen2026-04-22T00:02:42.703Zhttps://insights.citeline.com/companies/medigene-ag2026-04-22T00:02:36.638Zalways0.5Insightsen2026-04-22T00:02:36.638Zhttps://insights.citeline.com/companies/petros-pharmaceuticals-inc2026-04-22T00:02:24.663Zalways0.5Insightsen2026-04-22T00:02:24.663Zhttps://insights.citeline.com/companies/ucb-sa2026-04-22T00:02:18.716Zalways0.5Insightsen2026-04-22T00:02:18.716Zhttps://insights.citeline.com/companies/pepgen-inc2026-04-22T00:02:12.807Zalways0.5Insightsen2026-04-22T00:02:12.807Zhttps://insights.citeline.com/companies/mitsubishi-corporation2026-04-22T00:02:06.717Zalways0.5Insightsen2026-04-22T00:02:06.717Zhttps://insights.citeline.com/companies/atossa-therapeutics-inc2026-04-22T00:02:00.512Zalways0.5Insightsen2026-04-22T00:02:00.512Zhttps://insights.citeline.com/companies/calico-life-sciences-llc2026-04-22T00:01:54.429Zalways0.5Insightsen2026-04-22T00:01:54.429Zhttps://insights.citeline.com/companies/brainstorm-cell-therapeutics-inc2026-04-22T00:01:48.439Zalways0.5Insightsen2026-04-22T00:01:48.439Zhttps://insights.citeline.com/companies/phio-pharmaceuticals-corp2026-04-22T00:01:42.504Zalways0.5Insightsen2026-04-22T00:01:42.504Zhttps://insights.citeline.com/companies/portage-biotech-inc2026-04-22T00:01:36.423Zalways0.5Insightsen2026-04-22T00:01:36.423Zhttps://insights.citeline.com/companies/jaguar-health-inc2026-04-22T00:01:30.382Zalways0.5Insightsen2026-04-22T00:01:30.382Zhttps://insights.citeline.com/companies/paladin-pharma-inc2026-04-22T00:01:24.469Zalways0.5Insightsen2026-04-22T00:01:24.469Zhttps://insights.citeline.com/companies/palatin-technologies-inc2026-04-22T00:01:18.303Zalways0.5Insightsen2026-04-22T00:01:18.303Zhttps://insights.citeline.com/companies/esteve-pharmaceuticals-sa2026-04-22T00:01:12.323Zalways0.5Insightsen2026-04-22T00:01:12.323Z